Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Summary
To study the safety and clinical effects of intratumor injecting CpG-ODN and in situ release of tumor antigen by interventional ablation or drug-eluting beads to treat advanced solid tumors.
Official title: Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Released by Interventional Approaches for Advanced Solid Tumors
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2021-03-01
Completion Date
2036-06-30
Last Updated
2024-06-26
Healthy Volunteers
No
Interventions
CpG-ODN
CAR-T cells secreting scFv against OX40
Locations (1)
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China